These results were consistent after further adjustment for DM and hypertension (Model 1: OR, 2.28; 95% CI, 1.27–4.08; p = 0.005); for obesity, WC, and hyperuricemia (Model 2: OR, 2.28; 95% CI, 1.27–4.08; p = 0.005); and for lipid profile, AST, ALT, GGT, HOMA-IR, and hsCRP (Model 3: OR, 2.26; 95% CI, 1.26–4.04; p = 0.006). This evidence concerns the gene GPT and obesity due to melanocortin 4 receptor deficiency.